Offer - Urjas Oil for just ₹ 1 X
Dveniz ER 50 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Depression. The alternative uses of Dveniz ER 50 Tablet have also been explained below.
The right dosage of Dveniz ER 50 Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Dveniz ER 50 Tablet as well, which are listed below. Normally, these side effects of Dveniz ER 50 Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Dveniz ER 50 Tablet is Moderate for pregnant women and Unknown for women who are breastfeeding. In addition, Dveniz ER 50 Tablet's effects on the liver, heart and kidney are discussed below in the Dveniz ER 50 Tablet related warnings section.
Dveniz ER 50 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease are examples of such conditions. The section on Dveniz ER 50 Tablet contraindications lists all such conditions.
Besides this, Dveniz ER 50 Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Dveniz ER 50 Tablet is not safe while driving, and is is not addictive in nature.
Dveniz ER 50 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Dveniz ER 50 Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Dveniz. It is best to stop taking Dveniz immediately and inform your doctor if you notice any discomfort.
Is the use of Dveniz ER 50 Tablet safe during breastfeeding?
In the absence of any scientific study about the side effects of Dveniz in breastfeeding women, information on safety of Dveniz is unavailable.
What is the effect of Dveniz ER 50 Tablet on the Kidneys?
Kidney can be affected by Dveniz. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Dveniz ER 50 Tablet on the Liver?
You may experience side effects on your liver after taking Dveniz. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Dveniz ER 50 Tablet on the Heart?
The heart can be affected by Dveniz. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Dveniz ER 50 Tablet unless your doctor advises you to do so -
Is this Dveniz ER 50 Tablet habit forming or addictive?
No, there is no any evidence that Dveniz ER 50 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Dveniz ER 50 Tablet as you may feel sleepy.
Is it safe?
Yes, but consume Dveniz ER 50 Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Dveniz ER 50 Tablet in mental disorders is not effective.
Interaction between Food and Dveniz ER 50 Tablet
There isn't any research available on the side effects of taking Dveniz ER 50 Tablet with food.
Interaction between Alcohol and Dveniz ER 50 Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Dveniz ER 50 Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 416-417
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pristiq® (desvenlafaxine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Aptryxol™ (desvenlafaxine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Khedezla (desvenlafaxine)